Vaishali Pharma

VAISHALI30 Apr 2024

Trading

₹

-0.05 (-0.03%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Vaishali Pharma

Vaishali Pharma

Trading

VAISHALI30 Apr 2024

₹

-0.05 (-0.03%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
15-Oct-2019	B	3:5 Bonus Issue of Equity Shares	18-Oct-2019	3:5
25-Jan-2024	BC	To consider and approve the financial results for the period ended December 31, 2023 Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31,	02-Feb-2024
02-Jan-2024	BC	Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on January 02, 2024.	02-Jan-2024
01-Nov-2023	BC	To consider and approve the financial results for the period ended September 30, 2023 Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30	08-Nov-2023
05-Sep-2023	BC	Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on September 05, 2023. Oil India Limited has informed the Exchange regarding Proceedings of Annual General Meeting h	29-Sep-2023
05-Sep-2023	BC	Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on September 05, 2023.	23-Sep-2023

No Rights has been declared by VAISHALI

Book Closure

Record Date	Split Date	Purpose
02-Feb-2024	-	To consider and approve the financial results for the period ended December 31, 2023 Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31,
02-Jan-2024	-	Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on January 02, 2024.
08-Nov-2023	-	To consider and approve the financial results for the period ended September 30, 2023 Vaishali Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30
29-Sep-2023	-	Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on September 05, 2023. Oil India Limited has informed the Exchange regarding Proceedings of Annual General Meeting h
23-Sep-2023	01 Jan'1900	Vaishali Pharma Limited has informed the Exchange regarding Board meeting held on September 05, 2023.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Vaishali Pharma Ltd ₹158.50(-0.05/-0.03%)	158.50	-0.05	169.90	5.77	29.08	3.71
Integra Essentia Ltd ₹4.45(+0.20/4.71%)	4.45	+0.20	406.76	27.87	26.59	3.53
Kothari Products Ltd ₹136.25(+2.15/1.60%)	136.25	+2.15	406.62	18.27	81.01	0.42
Visagar Polytex Ltd ₹1.00(0.00/0.00%)	1.00	+0.00	29.27	11.11	0.00	1.82
Hexa Tradex Ltd ₹151.65(+0.60/0.40%)	151.65	+0.60	837.87	2.74	0.00	0.33
Future Consumer Ltd ₹0.90(0.00/0.00%)	0.90	+0.00	179.73	-25.00	0.00	-0.78

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	27.90	12.57	13.42	26.24	20.09	13.19
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	27.90	12.57	13.42	26.24	20.09	13.19
Other Operating Income	0.00	0.00	0.00	0.00	0.00	-0.03
Other Income	0.47	0.30	0.36	0.53	0.53	0.74
Total Income	28.37	12.86	13.78	26.77	20.62	13.89
Total Expenditure	24.94	9.91	11.11	25.46	16.53	10.56
PBIDT	3.42	2.95	2.67	1.31	4.08	3.33
Interest	0.43	0.47	0.43	0.54	0.42	0.53
PBDT	2.99	2.48	2.24	0.77	3.67	2.80
Depreciation	0.12	0.12	0.12	0.15	0.12	0.14
Tax	0.75	0.66	0.53	0.18	0.89	0.66
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	2.11	1.70	1.59	0.44	2.66	1.99
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	2.11	1.70	1.59	0.44	2.66	1.99

EPS (Unit Curr.)	1.99	1.61	1.50	0.41	2.52	1.89
EPS (Adj) (Unit Curr.)	1.99	1.61	1.50	0.41	2.52	1.89
Calculated EPS (Unit Curr.)	1.99	1.61	1.50	0.41	2.52	1.89
Calculated EPS (Adj) (Unit Curr.)	1.99	1.61	1.50	0.41	2.52	1.89
Calculated EPS (Ann.) (Unit Curr.)	7.97	6.43	5.99	1.65	10.10	7.56
Calculated EPS (Adj) (Ann.) (Unit Curr.)	7.97	6.43	5.99	1.65	10.10	7.56
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	10.60	10.60	10.60	10.55	10.55	10.55
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	12.26	23.47	19.90	4.99	20.31	25.25
PBDTM(%)	10.72	19.73	16.69	2.93	18.27	21.23
PATM(%)	7.56	13.52	11.85	1.68	13.24	15.09

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	10.55	10.55	10.55	10.55	6.59	6.59
Reserves Total	29.99	15.81	11.87	10.84	14.81	14.01
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	40.54	26.36	22.42	21.39	21.40	20.60
Secured Loans	13.00	15.03	17.30	16.28	16.72	15.77
Unsecured Loans	1.73	5.78	0.55	0.76	0.35	2.63
Total Debt	14.73	20.81	17.85	17.04	17.07	18.40
Total Liabilities	55.27	47.17	40.27	38.43	38.47	39.00
APPLICATION OF FUNDS :
Gross Block	3.85	3.30	2.89	2.73	2.14	1.79
Less : Accumulated Depreciation	1.86	2.12	1.67	1.24	0.80	0.53
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1.99	1.18	1.22	1.49	1.34	1.26
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.67	0.49	0.05	0.08	0.04	0.08
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.43	0.43	0.43	0.43	0.43	0.43
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	3.05	0.63	0.59	0.88	0.98	1.87
Sundry Debtors	53.61	58.51	66.73	47.03	49.42	44.58
Cash and Bank	0.98	1.36	0.47	0.38	0.32	0.28
Loans and Advances	15.03	15.94	13.51	12.93	12.25	12.32
Total Current Assets	72.67	76.43	81.29	61.21	62.97	59.05
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	21.47	32.96	45.28	27.56	29.44	24.66
Provisions	1.97	1.31	0.39	0.08	0.74	0.39
Total Current Liabilities	23.44	34.27	45.67	27.64	30.18	25.04
Net Current Assets	49.23	42.16	35.62	33.57	32.79	34.01
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.14	0.16	0.15	0.12	0.11	0.12
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.14	0.16	0.15	0.12	0.11	0.12
Total Assets	52.45	44.42	37.46	35.69	34.70	35.91
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	1.36	0.47	0.38	0.32	0.28
Net Cash from Operating Activities	1.08	1.32	2.01	3.22	4.31
Net Cash Used In Investing Activities	0.28	-0.85	-0.11	-0.02	-0.28
Net Cash Used In Financing Activities	-1.73	0.42	-1.81	-3.14	-3.99
Net Inc./Dec In Cash And Cash Equivalents	-0.37	0.89	0.09	0.06	0.04
Cash And Cash Equivalents At End Of The Year	0.98	1.36	0.47	0.38	0.32

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

26.32%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

73.68%

**Promoter pledged shareholding 26.32%

About Vaishali Pharma Ltd

Vaishali Pharma Ltd is in the Trading sector, having a market capitalization of Rs. 169.9 crores. It has reported a sales of Rs. 27.9 crores and a net profit of Rs. 2.11 crores for the quarter ended December 2018. The company management includes Atul Vasani, Atul Vasani,Jagruti Vasani,Dewansh Vasani,Ashvin Jamnadas Ganatra,Manish Bhagwandas Ved,Vishwa Mekhia,Pratik Vikram Jakhelia (Vaishali Pharma Ltd) among others.

Chairman

Atul Vasani

Registered office

706 to 709 7th Floor Aravali,Business Centre Borivali(W),Mumbai,Maharashtra,400092

FAX :91-22-28928833

Background

Incorporation Year2008

Face Value₹10

Market Lot1

How to buy Vaishali Pharma shares on nse?

To buy Vaishali Pharma shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Vaishali Pharma share price today?

The Vaishali Pharma shares price on nse is Rs.158.5 today.

What is the market cap of Vaishali Pharma shares on NSE ?

The company has a market capitalization of Rs.169.90Cr

What is the PE & PB ratio of Vaishali Pharma shares ?

PE is 29.08 and PB is 3.71

What is the 52 Week High and Low of Vaishali Pharma shares?

Vaishali Pharma stock price high: Rs.203.6 Vaishali Pharma stock price low: Rs.114.85